Replies to post #80989 on PharmaCyte Biotech Inc (PMCB)

[BioInvestor4]

I look at it like this. They replaced Chardon with a new financing company. It’s gives PMCB the necessary money to pay for trial if needed (and it probably is needed as I don’t buy into the partner theory). So the positive is in a worst case scenario they have funding. The downside is obviously dilution if it’s used... I don’t think anybody in this doesn’t understand the money for trial has to come from somewhere.. so Imho, it’s needed.

[efood125]

Does not bother me at all...part of business readiness....It's possible AEON has a interested client lined up...Let's see

[ace1234]

Not really. It's just basic stock politics.

You have to look at the big picture. We've got world renown oncologists working with us & many other great things.

Just wait for the IND and trial.